Drug intervention as an emerging concept for secondary prevention in patients with coronary disease

Area of Science:

• Cardiology
• Vascular Biology
• Pharmacology

Background:

• Non-culprit lesion events are a significant concern in coronary artery disease (CAD).
• Vulnerable plaques in non-culprit lesions are prevalent at initial coronary events.
• Immediate plaque stabilization may reduce adverse events.

Purpose of the Study:

• To discuss the concept of 'Drug Intervention' for immediate plaque stabilization.
• To raise awareness of reducing recurrent coronary events through early pharmacological intervention.
• To highlight the role of intensive lipid-lowering therapy in CAD management.

Main Methods:

• Review of current literature on intra-coronary imaging and pharmacological interventions.
• Analysis of studies investigating the efficacy of intensive statin and PCSK9 inhibitor regimens.
• Discussion of the concept of 'Drug Intervention' in clinical practice.

Main Results:

• Intensive lipid-lowering therapy, including statins and PCSK9 inhibitors, demonstrates efficacy in stabilizing non-culprit coronary plaques.
• Early and intensive regimens achieve lower low-density lipoprotein cholesterol (LDL-C) goals more effectively.
• Studies show a higher percentage of patients attaining LDL-C treatment goals early post-discharge with intensive therapy.

Conclusions:

• Immediate plaque stabilization via intensive pharmacological regimens is crucial for reducing recurrent cardiovascular events in CAD patients.
• The concept of 'Drug Intervention' emphasizes early and aggressive lipid-lowering therapy.
• Further research and clear definitions are needed to optimize 'Drug Intervention' strategies, particularly for acute coronary syndrome patients.